WaveMan · Form 4
Dobmeier Eric insider trades
> Search tickers & screens ⌘K
LIVE

Dobmeier Eric insider trades

Dobmeier Eric has filed 26 Form 4s with the SEC that we hold, for KDNY (President, CEO, Director), Janux Therapeutics, Inc. (JANX) (Director), Atara Biotherapeutics, Inc. (ATRA) (Director) and Structure Therapeutics Inc. (GPCR) (Director), among 5 companies in all. Across all of them we count 5 purchases worth $310.1K and 6 sales worth $2.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 30,000 shares of KDNY worth $669.3K, dated 2022-12-01. The first filing on our record is dated 2021-08-19 and the latest 2026-06-18.

KDNY

President, CEO, Director · 14 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-18P, purchase reported on Form 47,000$82.2K2021-08-19
2021-08-19P, purchase reported on Form 43,000$36.0K2021-08-19
2021-09-20P, purchase reported on Form 42,000$24.0K2021-09-22
2022-05-25P, purchase reported on Form 45,000$65.2K2022-05-27
2022-12-01S, sale reported on Form 430,000$669.3K2022-12-02
2023-01-30S, sale reported on Form 425,000$613.5K2023-02-01
2023-01-31S, sale reported on Form 47,688$189.7K2023-02-01
2023-02-10S, sale reported on Form 48,097$192.3K2023-02-15
2023-04-24S, sale reported on Form 41,200$26.7K2023-04-26
2023-04-24S, sale reported on Form 423,800$513.6K2023-04-26

Janux Therapeutics, Inc. (JANX)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Atara Biotherapeutics, Inc. (ATRA)

Director · 3 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-11-10P, purchase reported on Form 4446,825$102.8K2023-11-14

Structure Therapeutics Inc. (GPCR)

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Jade Biosciences, Inc. (JBIO)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1202785) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms